trial · primary record
Immunomodulatory DC vaccine to target DIPG and GBM
Diffuse Intrinsic Pontine Glioma or Glioblastoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Safety of infusion of autologous immunomodulatory DC Vaccine is assessed by the NCI CTCAE V4.0 criteria. |
| Registry ID | NCT03914768 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:52.535Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03914768
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.